CYPHERPUNK TECHNOLOGIES INC. (CYPH)
$1.80+$0.09 (+5.26%) TodayExtended Hours
Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 20,000 | $34K |
| Grant or award | 9 | 4,500,000 | |
| Other acquisition / disposition | 6 | 152,863,492 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
63 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Thomas John Dietz - Director | Open-market sale | Common Stock | 20,000 | $1.72 | $34K | |
| Kevin Zhang - Officer | Grant or award | Restricted Stock Units | 2,000,000 | $0.00 | - | |
| William Patrick McEvoy III - Officer | Other | Common Stock | 16,570,852 | $0.00 | $17K | |
| William Patrick McEvoy III - Officer | Other | Pre-Funded Warrant (Right to Buy) | 16,570,852 | $0.52 | $8.61M | |
| William Patrick McEvoy III - Officer | Other | Pre-Funded Warrant (Right to Buy) | 43,290,042 | $0.77 | $33.33M | |
| Winklevoss Capital Fund, LLC - 10% Owner | Other | Common Stock | 16,570,852 | $0.00 | $17K | |
| Winklevoss Capital Fund, LLC - 10% Owner | Other | Pre-Funded Warrant (Right to Buy) | 16,570,852 | $0.52 | $8.61M | |
| Winklevoss Capital Fund, LLC - 10% Owner | Other | Pre-Funded Warrant (Right to Buy) | 43,290,042 | $0.77 | $33.33M | |
| Christian M. Richard - Director | Grant or award | Restricted Stock Units | 75,000 | $0.00 | - | |
| Khing Djien Oei - Director | Grant or award | Restricted Stock Units | 100,000 | $0.00 | - | |
| Thomas John Dietz - Director | Grant or award | Restricted Stock Units | 100,000 | $0.00 | - | |
| Patricia A. Martin - Director | Grant or award | Restricted Stock Units | 75,000 | $0.00 | - | |
| William Li - Director | Grant or award | Restricted Stock Units | 75,000 | $0.00 | - | |
| Douglas E. Onsi - Officer | Grant or award | Restricted Stock Units | 1,000,000 | $0.00 | - | |
| William Patrick McEvoy III - Officer | Grant or award | Restricted Stock Units | 1,000,000 | $0.00 | - | |
| Nissim Mashiach - Director | Grant or award | Restricted Stock Units | 75,000 | $0.00 | - | |
| Christopher Mirabelli - Director | Open-market sale | Common Stock | 60,000 | $0.71 | $43K | |
| Thomas John Dietz - Director | Option exercise | Common Stock | 104,500 | - | - | |
| Thomas John Dietz - Director | Option exercise | Restricted Stock Units | 104,500 | $0.00 | - | |
| Christopher Mirabelli - Director | Option exercise | Restricted Stock Units | 94,050 | $0.00 | - | |
| Christopher Mirabelli - Director | Option exercise | Common Stock | 74,700 | - | - | |
| Christopher Mirabelli - Director | Option exercise | Common Stock | 94,050 | - | - | |
| Christopher Mirabelli - Director | Option exercise | Restricted Stock Units | 74,700 | $0.00 | - | |
| Khing Djien Oei - Director | Option exercise | Common Stock | 94,050 | - | - | |
| Khing Djien Oei - Director | Option exercise | Restricted Stock Units | 74,700 | $0.00 | - | |
| Khing Djien Oei - Director | Option exercise | Restricted Stock Units | 94,050 | $0.00 | - | |
| Khing Djien Oei - Director | Option exercise | Common Stock | 74,700 | - | - | |
| William Li - Director | Option exercise | Common Stock | 74,700 | - | - | |
| William Li - Director | Option exercise | Common Stock | 94,050 | - | - | |
| William Li - Director | Option exercise | Restricted Stock Units | 74,700 | $0.00 | - | |
| William Li - Director | Option exercise | Restricted Stock Units | 94,050 | $0.00 | - | |
| Christian M. Richard - Director | Option exercise | Restricted Stock Units | 94,050 | $0.00 | - | |
| Christian M. Richard - Director | Option exercise | Common Stock | 74,700 | - | - | |
| Christian M. Richard - Director | Option exercise | Common Stock | 94,050 | - | - | |
| Christian M. Richard - Director | Option exercise | Restricted Stock Units | 74,700 | $0.00 | - | |
| Nissim Mashiach - Director | Option exercise | Restricted Stock Units | 94,050 | $0.00 | - | |
| Nissim Mashiach - Director | Option exercise | Common Stock | 74,700 | - | - | |
| Nissim Mashiach - Director | Option exercise | Common Stock | 94,050 | - | - | |
| Nissim Mashiach - Director | Option exercise | Restricted Stock Units | 74,700 | $0.00 | - | |
| Patricia A. Martin - Director | Option exercise | Restricted Stock Units | 94,050 | $0.00 | - | |
| Patricia A. Martin - Director | Option exercise | Common Stock | 74,700 | - | - | |
| Patricia A. Martin - Director | Option exercise | Common Stock | 94,050 | - | - | |
| Patricia A. Martin - Director | Option exercise | Restricted Stock Units | 74,700 | $0.00 | - | |
| Richard Schilsky - Director | Option exercise | Restricted Stock Units | 74,700 | $0.00 | - | |
| Richard Schilsky - Director | Option exercise | Restricted Stock Units | 94,050 | $0.00 | - | |
| Richard Schilsky - Director | Option exercise | Common Stock | 74,700 | - | - | |
| Richard Schilsky - Director | Option exercise | Common Stock | 94,050 | - | - | |
| Joseph Loscalzo - Director | Option exercise | Restricted Stock Units | 94,050 | $0.00 | - | |
| Joseph Loscalzo - Director | Option exercise | Common Stock | 74,700 | - | - | |
| Joseph Loscalzo - Director | Option exercise | Common Stock | 94,050 | - | - | |
| Joseph Loscalzo - Director | Option exercise | Restricted Stock Units | 74,700 | $0.00 | - | |
| James H. Cavanaugh - Director | Option exercise | Restricted Stock Units | 74,700 | $0.00 | - | |
| James H. Cavanaugh - Director | Option exercise | Restricted Stock Units | 94,050 | $0.00 | - | |
| James H. Cavanaugh - Director | Option exercise | Common Stock | 74,700 | - | - | |
| James H. Cavanaugh - Director | Option exercise | Common Stock | 94,050 | - | - | |
| Winklevoss Capital Fund, LLC | Gift | Warrant (Right to Buy) | 5,616,906 | $0.13 | $702K | |
| Christopher Mirabelli - Director | Open-market sale | Common Stock | 261,840 | $3.14 | $822K | |
| Christopher Mirabelli - Director | Open-market sale | Common Stock | 414,479 | $3.14 | $1.30M | |
| Douglas E. Onsi - Officer | Open-market sale | Common Stock | 414,479 | $3.14 | $1.30M | |
| Douglas E. Onsi - Officer | Open-market sale | Common Stock | 261,840 | $3.14 | $822K | |
| James H. Cavanaugh - Director | Open-market sale | Common Stock | 261,840 | $3.14 | $822K | |
| James H. Cavanaugh - Director | Grant or award | Restricted Stock Units | 74,700 | $0.00 | - | |
| William Li - Director | Grant or award | Restricted Stock Units | 74,700 | $0.00 | - | |
| Richard Schilsky - Director | Grant or award | Restricted Stock Units | 74,700 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Dietz Thomas John | Director | 20,000 | $32K | View on EDGAR |
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had 12 insider filings in the last 90 days, with the most recent on 2026-08-27. The full record for CYPH runs to 63 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of CYPH were filed in the last 90 days.
1 insider sale of CYPH was filed in the last 90 days, totaling $34K.
This page tracks CYPH Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add CYPH to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
